Demand for weight-loss drugs fuels global rise in counterfeits

About Author

Picture of Oren Todoros

Oren Todoros

Oren is a cybersecurity and digital risk intelligence expert at BrandShield, focused on protecting organizations from online fraud, brand impersonation, and phishing attacks. He writes about emerging threats across digital ecosystems and strategies for proactive brand protection at scale.

BrandShield combines advanced AI and expert enforcement to help brands detect and remove online threats fast. Stop infringement, safeguard your reputation, and build lasting trust; all in one platform. Book a demo to learn more.

Extraordinary demand for Novo Nordisk’s. Ozempic and other drugs used for weight-loss is fueling a global surge in counterfeit versions, according to Reuters interviews with law enforcement, anti-counterfeiting and public health officials.

Get a Free Brand Assestment

See how BrandShield uncovers counterfeit networks, detects brand abuse across marketplaces, social and AI platforms, and removes threats quickly and at scale.

Recommended for you